421 related articles for article (PubMed ID: 21304573)
1. [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2011 Feb; 131(3):244-7. PubMed ID: 21304573
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk associated with chronic use of bisphosphonates: evidence today.
Charopoulos I; Orme S; Giannoudis PV
Expert Opin Drug Saf; 2011 Jan; 10(1):67-76. PubMed ID: 21121870
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate treatment of pediatric bone disease.
Speiser PW; Clarson CL; Eugster EA; Kemp SF; Radovick S; Rogol AD; Wilson TA;
Pediatr Endocrinol Rev; 2005 Dec; 3(2):87-96. PubMed ID: 16361982
[TBL] [Abstract][Full Text] [Related]
4. [The successful development of bisphosphonates in the therapy of osteoporosis].
Fassbender WJ; Stumpf UC; Kurth A
Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonate].
Hagino H
Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
[TBL] [Abstract][Full Text] [Related]
6. A once-yearly IV bisphosphonate for osteoporosis.
Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
[No Abstract] [Full Text] [Related]
7. Bisphosphonate therapy and dental treatment.
Phillips G
J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
[No Abstract] [Full Text] [Related]
8. Bisphosphonates in the treatment of osteoporosis.
Diab DL; Watts NB
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.
Drake MT; Cremers SC
Mol Interv; 2010 Jun; 10(3):141-52. PubMed ID: 20539033
[TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonate].
Hagino H
Nihon Rinsho; 2015 Oct; 73(10):1683-9. PubMed ID: 26529930
[TBL] [Abstract][Full Text] [Related]
11. [Bisphosphonate therapy for osteoporosis and bone strength].
Kishimoto H
Clin Calcium; 2006 Sep; 16(9):1513-19. PubMed ID: 16951477
[TBL] [Abstract][Full Text] [Related]
12. Safety of bisphosphonates.
Orozco C; Maalouf NM
Rheum Dis Clin North Am; 2012 Nov; 38(4):681-705. PubMed ID: 23137577
[TBL] [Abstract][Full Text] [Related]
13. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
Sone T
Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
McClung M; Harris ST; Miller PD; Bauer DC; Davison KS; Dian L; Hanley DA; Kendler DL; Yuen CK; Lewiecki EM
Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
[TBL] [Abstract][Full Text] [Related]
15. Atypical femoral fractures and their relation to bisphosphonate use.
Tripto-Shkolnik L
Isr Med Assoc J; 2013 Aug; 15(8):447-50. PubMed ID: 24079069
[No Abstract] [Full Text] [Related]
16. [A query from medical practice: the biological half-life of biphosphonates].
Bartl R
Dtsch Med Wochenschr; 2008 Dec; 133(51-52):2700-1. PubMed ID: 19067274
[No Abstract] [Full Text] [Related]
17. [Atypical femoral fractures in long-term osteoporotic treatment with bisphosphonates].
Thein R; Tenenbaum S; Chechick O; Hershkovitz O; Chechik A; Caspi I
Harefuah; 2012 Sep; 151(9):532-6, 555. PubMed ID: 23367748
[TBL] [Abstract][Full Text] [Related]
18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of weekly bisphosphonates.
Rizzoli R
Clin Orthop Relat Res; 2006 Feb; 443():61-5. PubMed ID: 16462427
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonate-associated osteonecrosis of the jaws 1].
Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
